Why choose ERC?Our 99% retention rate says it all
We’re an esteemed clinical practice, with a team of committed medical and research professionals – recognized for combining superior volunteer recruitment and retention with outstanding clinical trial conduct.
We understand that clinical trial recruitment can be difficult. So, if you’ve never worked with us before, you may have concerns. Let’s address them.
Why choose ERC? Our 99% retention rate says it all
We’re an esteemed clinical practice, with a team of committed medical and research professionals – recognized for combining superior volunteer recruitment and retention with outstanding clinical trial conduct.
We understand that clinical trial recruitment can be difficult. So, if you’ve never worked with us before, you may have concerns. Let’s address them.
Specialty areas
Diabetes
(Type 1 & 2)
Hypothyroidism
Cardiovascular Disease
Chronic Kidney Disease
YOUR DILEMMAS
OUR DELIVERABLES
It’s hard to find patients interested in a
trial.
We generally recruit patients who we know and work with.
Screening ineligible patients loses you time and money.
We keep the reins on screening and pre-screening; we try to know ahead of time if a patient will qualify.
It's difficult to get a patient to stick with long clinical trials.
Our research and medical professionals build strong ERC-patient relationships, affirming patients’ determination to stay through the entire trial.
Inadvertently signing up “lost-to-follow-up patients”.
With our exceptional screening process, trusted patient relationships, and informed consent, OmniTrace services – we have a 99% follow-up and retention success rate.
Clinical trials
MUIR-3 STUDY
protocol number: AROAPOC3-3009
sponsor: Arrowhead Pharmaceuticals
ONGOING
SHASTA-4 STUDY
protocol number: AROAPOC3-3004
sponsor: Arrowhead Pharmaceuticals
ONGOING
MBX-2H1002 Study (Avail-EXT)
sponsor: MBX Biosciences
ONGOING
Redefine
protocol number: NN9838-4942
sponsor: Novo Nordisk
ONGOING
Combine 4
Protocol number: NN1535-4988
sponsor: Novo Nordisk
completed: 2023
Achieve-3
protocol number: J2A-MC-GZGU
sponsor: Eli Lilly
ONGOING
Achieve 4
protocol number: J2A-MC-GZGS
sponsor: Eli Lilly
ONGOING
RTA 901
protocol number: AROAPOC3-3009,
sponsor: Reata Pharmaceuticals
completed: 2023
CORT125134-452
sponsor: Corcept Therapeutics
completed: 2023
Sention
completed: 2022
COMBINE 2
completed: 2022
Gradient
protocol number: AROAPOC3-3009,
sponsor: CORT125134-456
Surmount 2
protocol number: I8F-MC-GPIJ
sponsor: Eli Lilly
completed: 2021
Onwards 2
protocol number: NN1436-4478
sponsor: Novo Nordisk
completed: 2021
ZEUS
protocol number: EX6018-4758
sponsor: Novo Nordisk
completed: 2021
SURPASS-CVOT
Protocol number: I8F-MC-GPGN
sponsor: Eli Lilly
completed: 2023
Harmony Outcomes,
completed: 2015
CREDENCE TRIAL
completed: 2015
SUSTAIN-5
protocol number: NN9535-4801
sponsor: Novo Nordisk
completed: 2015
AMPLITUDE-O
protocol number: EFC14828
sponsor: Sanofi
completed: 2018
CLEAR OUTCOMES
protocol number: 1002-043
sponsor: Espeion Therapeutics
completed: 2017
CALCILYTIX
protocol number: CLTX-305-901
completed: 2021
protocol number: J1I-MC-GZBD
sponsor: Eli Lilly
completed: 2021
protocol number: AJ2A-MC-GZGI
sponsor: Eli Lilly
completed: 2021
protocol number: I8F-MC-GPHD
sponsor: Eli Lilly
completed: 2021
protocol number: I8F-MC-GPHL
sponsor: Eli Lilly
completed: 2022
protocol number: I8F-MC-BDCP
sponsor: Arrowhead Pharmaceuticals
completed: 2022
Prominent
protocol number: K-877-302
sponsor: Kowa
completed: 2019
200+
Patient participants
17
Sponsoring partners
48
Successful clinical trials
13
Years of experience
Hear from our sponsors
I have worked with the Dr. Tan and her site staff at Fort Worth Endocrine Research Center on multiple trials for the past 5 years. The entire staff, particularly the clinical research coordinator, Chelsea Padilla, is highly professional, well-organized, and always prepared for monitoring visits. Donna Cavaness, Regulatory Specialist, has been a superstar with maintaining the regulatory documents. Their attention to detail in record-keeping and consistent communication streamlined the entire process. They successfully recruited and retained participants while maintaining a high standard of data accuracy and integrity. This site is very accommodating and super friendly. I enjoy working with Dr. Tan and her site staff! Future studies would benefit from their services.
A.C.